• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Best of luck DT


<



Similar threads

Replies
23
Views
3K
Eisai
anonymous
Replies
0
Views
1K
Eisai
Anonymous
Replies
23
Views
4K
Eisai
Anonymous